Cyclophilin A cooperates with MIP-2 to augment neutrophil migration

Background Chemokines contribute to inflammatory responses by inducing leukocyte migration and extravasation. In addition, chemoattractants other than classical chemokines can also be present. Many chemokines have been demonstrated to cooperate, leading to an augmentation in leukocyte recruitment and providing a potential role for the presence of multiple chemoattractants. Extracellular cyclophilins are a group of alternative chemotactic factors, which can be highly elevated during various inflammatory responses and, as we have previously shown, can contribute significantly to neutrophil recruitment in an animal model of acute lung inflammation. In the current studies we investigated whether the most abundant extracellular cyclophilin, CypA, has the capacity to function in partnership with 2 classical chemokines known to be secreted in the same model, macrophage inflammatory protein (MIP)-2/CXCL2 and keratinocyte chemoattractant (KC)/CXCL1. Methods Neutrophil migration in response to combinations of CypA and MIP-2 or CypA and KC was measured by in vitro chemotaxis assays. Biochemical responses of neutrophils incubated with the combinations of chemoattractants were determined by changes in chemokine receptor internalization and actin polymerization measured by flow cytometry, and changes in intracellular calcium mobilization measured with a calcium sensitive fluorochrome. Results A combination of CypA and MIP-2, but not KC, augmented neutrophil migration. Based on the level of augmentation, the cooperation between CypA and MIP-2 appeared to be synergistic. Evidence that CypA and MIP-2 cooperate at the biochemical level was demonstrated by increases in receptor internalization, calcium mobilization, and actin polymerization. Conclusion These findings provide evidence for the capacity of extracellular cyclophilins to interact with classical chemokines, resulting in greater and more efficient leukocyte recruitment.

[1]  Peter C Dedon,et al.  Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates , 2010, International journal of cancer.

[2]  M. Halterman,et al.  The paradox of the neutrophilˈs role in tissue injury , 2010, Journal of leukocyte biology.

[3]  G. Opdenakker,et al.  CC chemokine ligand‐2 synergizes with the nonchemokine G protein‐coupled receptor ligand fMLP in monocyte chemotaxis, and it cooperates with the TLR ligand LPS via induction of CXCL8 , 2009, Journal of leukocyte biology.

[4]  M. Locati,et al.  Synergy‐inducing chemokines enhance CCR2 ligand activities on monocytes , 2009, European journal of immunology.

[5]  M. Bukrinsky,et al.  Targeting the chemotactic function of CD147 reduces collagen‐induced arthritis , 2009, Immunology.

[6]  M. Parmentier,et al.  Synergy between Coproduced CC and CXC Chemokines in Monocyte Chemotaxis through Receptor-Mediated Events , 2008, Molecular Pharmacology.

[7]  E. Matsui,et al.  Novel Approach to Inhibit Asthma-Mediated Lung Inflammation Using Anti-CD147 Intervention , 2007, Pediatrics.

[8]  C. Vanpouille,et al.  Syndecan-1/CD147 association is essential for cyclophilin B-induced activation of p44/42 mitogen-activated protein kinases and promotion of cell adhesion and chemotaxis. , 2007, Glycobiology.

[9]  M. Bukrinsky,et al.  Dealing with the family: CD147 interactions with cyclophilins , 2006, Immunology.

[10]  P. Proost,et al.  Synergy in cytokine and chemokine networks amplifies the inflammatory response. , 2005, Cytokine & growth factor reviews.

[11]  M. Bukrinsky,et al.  Extracellular Cyclophilins Contribute to the Regulation of Inflammatory Responses1 , 2005, The Journal of Immunology.

[12]  G. Opdenakker,et al.  Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue , 2005, European journal of immunology.

[13]  M. Uguccioni,et al.  CCL22‐induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first β‐strand of chemokine , 2005, European journal of immunology.

[14]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[15]  S. Young,et al.  Transcriptional Profiling of Lipopolysaccharide-Induced Acute Lung Injury , 2004, Infection and Immunity.

[16]  S. Hussey,et al.  Synergy between IL-8 and GM-CSF in reproductive tract epithelial cell secretions promotes enhanced neutrophil chemotaxis. , 2004, Cellular immunology.

[17]  Liang Xie,et al.  Cyclophilin A Is a Proinflammatory Cytokine that Activates Endothelial Cells , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[18]  P. Proost,et al.  Synergy between proinflammatory ligands of G protein‐coupled receptors in neutrophil activation and migration , 2004, Journal of leukocyte biology.

[19]  H. Bang,et al.  Elevated Serum Cyclophilin Levels in Patients with Severe Sepsis , 1997, Journal of Clinical Immunology.

[20]  M. Stanford,et al.  The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo , 2003, Journal of leukocyte biology.

[21]  William C. Parks,et al.  Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.

[22]  W. Seeger,et al.  The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. , 2002, American journal of respiratory and critical care medicine.

[23]  M. Bukrinsky Cyclophilins: unexpected messengers in intercellular communications. , 2002, Trends in immunology.

[24]  P. Proost,et al.  The unique property of the CC chemokine regakine-1 to synergize with other plasma-derived inflammatory mediators in neutrophil chemotaxis does not reside in its NH2-terminal structure. , 2002, Molecular pharmacology.

[25]  M. Bukrinsky,et al.  Active Site Residues of Cyclophilin A Are Crucial for Its Signaling Activity via CD147* , 2002, The Journal of Biological Chemistry.

[26]  M. Bukrinsky,et al.  CD147 is a signaling receptor for cyclophilin B. , 2001, Biochemical and biophysical research communications.

[27]  Mario Mellado,et al.  Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.

[28]  P. Proost,et al.  Identification of a blood-derived chemoattractant for neutrophils and lymphocytes as a novel CC chemokine, Regakine-1. , 2001, Blood.

[29]  C. Yan,et al.  Cyclophilin A is a secreted growth factor induced by oxidative stress. , 2000, Circulation research.

[30]  Hua,et al.  Identification of , 2000, Journal of insect physiology.

[31]  P. Gallay,et al.  Host cyclophilin A mediates HIV‐1 attachment to target cells via heparans , 1999, The EMBO journal.

[32]  S. McColl,et al.  Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists. , 1999, Journal of immunology.

[33]  G. Spik,et al.  Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes. , 1998, The Biochemical journal.

[34]  A. Rot,et al.  Presence of Cyclophilin A in Synovial Fluids of Patients with Rheumatoid Arthritis , 1997, The Journal of experimental medicine.

[35]  T. Standiford,et al.  Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. , 1996, The Journal of infectious diseases.

[36]  P K Gessner,et al.  Isobolographic analysis of interactions: an update on applications and utility. , 1995, Toxicology.

[37]  A. Cerami,et al.  Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  A. El-Sohemy,et al.  Journal of Inflammation Research , 2022 .